ASCO panel outlines cancer care challenges during COVID-19 pandemicApril 27, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Will coronavirus restrictions lead to more advanced cancers?April 23, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
European cancer centers restructure care in the era of COVID-19April 22, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Want to keep cancer patients and providers safe during the pandemic? Here’s howApril 20, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Cancer patients report delays in treatment because of COVID-19April 17, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Cancer care ‘transformed in space of a month’ because of pandemicApril 17, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
ASCO announces its own COVID-19 and cancer registryApril 13, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Cancer prevalence among COVID-19 patients may be higher than previously reportedApril 13, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanoma
When to treat, delay, or omit breast cancer therapy in the face of COVID-19April 10, 2020Breast CancerOncology
Home-based chemo skyrockets at one U.S. centerApril 10, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Conducting cancer trials amid the COVID-19 pandemicApril 8, 2020MelanomaLymphoma & Plasma Cell DisordersLung CancerLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersGenitourinary CancerBreast Cancer
Advice from the front lines: How cancer centers can cope with COVID-19April 2, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
20% with cancer on checkpoint inhibitors get thyroid dysfunctionApril 2, 2020OncologyBreast CancerLung CancerLymphoma & Plasma Cell Disorders
CLL and breast cancer differ in the expression of regulatory microRNAsMarch 25, 2020Breast CancerOncologyHematology
Cancer care and COVID-19 in Seattle, the first U.S. epicenterMarch 23, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
